Natalia Malikowska-Racia
12 Smętna Str
Krakow, MA 31324, Poland
Krakow, MA 31324, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Dually Acting Ligands Targeting Serotonin Receptors: Implications in CNS Disorders.
Journal: Journal of medicinal chemistry
Published: April 27, 2026
Effects of ketamine enantiomers on morphine and THC subjective effects in rats.
Journal: Journal of psychopharmacology (Oxford, England)
Published: December 26, 2025
Naltrexone dose-selectively modulates goal-directed behavior and the hypothalamic proteome in rats.
Journal: Pharmacological reports : PR
Published: March 27, 2025
Effects of ketamine on rat social behavior as analyzed by DeepLabCut and SimBA deep learning algorithms.
Journal: Frontiers in pharmacology
Published: October 28, 2023
Acute but not long-lasting antidepressant-like effect of psilocybin in differential reinforcement of low-rate 72 schedule in rats.
Journal: Journal of psychopharmacology (Oxford, England)
Published: October 16, 2023
Novel object recognition test as an alternative approach to assessing the pharmacological profile of sigma-1 receptor ligands.
Journal: Pharmacological reports : PR
Published: June 16, 2023
Effects of ketamine optical isomers, fluoxetine and naloxone on timing in differential reinforcement of low-rate response (DRL) 72-s task in rats.
Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Published: September 01, 2022
Overcoming undesirable hERG affinity by incorporating fluorine atoms: A case of MAO-B inhibitors derived from 1 H-pyrrolo-[3,2-c]quinolines.
Journal: European journal of medicinal chemistry
Published: January 27, 2022
Structure-Based Design and Optimization of FPPQ, a Dual-Acting 5-HT3 and 5-HT6 Receptor Antagonist with Antipsychotic and Procognitive Properties.
Journal: Journal of medicinal chemistry
Published: September 01, 2021
Synthesis and Evaluation of the Antidepressant-like Properties of HBK-10, a Novel 2-Methoxyphenylpiperazine Derivative Targeting the 5-HT1A and D2 Receptors.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: July 03, 2021
Last Updated: 09/26/2026